Proteins in our blood could in the future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of diseases, according to research published in Nature Medicine. The research was conducted by a team of researchers, including co-author Dr. Mark Sarzynski, assistant professor of exercise science at the University of South Carolina Arnold School of Public Health.
Preventative medicine programs, such as the United Kingdom’s National Health Service’s Health Check and Healthier You, are aimed at improving our health and reducing our risk of developing diseases. While such strategies are inexpensive, cost-effective and scalable, they could be made more effective using personalized information about an individual’s health and disease risk.
The rise and application of ‘big data’ in healthcare, assessing and analyzing detailed, large-scale datasets makes it increasingly feasible to make predictions about health and disease outcomes and enable stratified approaches to prevention and clinical management.
Now, an international team of researchers from the UK and USA, working with biotech company SomaLogic, has shown that large-scale measurement of proteins in a single blood test can provide important information about our health and can help to predict a range of different diseases and risk factors.Friday Letter Submission, Publish on December 13